Par Drugs And Chemicals Limited (PAR) - Total Liabilities
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has total liabilities worth Rs172.28 Million INR (≈ $1.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Par Drugs And Chemicals Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Par Drugs And Chemicals Limited - Total Liabilities Trend (2016–2026)
This chart illustrates how Par Drugs And Chemicals Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Par Drugs And Chemicals Limited's balance sheet.
Par Drugs And Chemicals Limited Competitors by Total Liabilities
The table below lists competitors of Par Drugs And Chemicals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Volitionrx Ltd
NYSE MKT:VNRX
|
USA | $42.49 Million |
|
Kodi-S Co Ltd
KQ:080530
|
Korea | ₩24.56 Billion |
|
Seker Finansal Kiralama AS
IS:SEKFK
|
Turkey | TL4.13 Billion |
|
Knightscope Inc
NASDAQ:KSCP
|
USA | $13.49 Million |
|
Salee Colour Public Company Limited
BK:COLOR
|
Thailand | ฿518.52 Million |
|
YOC AG
F:YOC
|
Germany | €13.25 Million |
|
Lleidanetworks Serveis Telematics SA
MC:LLN
|
Spain | €11.70 Million |
|
Telefast Indonesia
JK:TFAS
|
Indonesia | Rp42.65 Billion |
Liability Composition Analysis (2016–2026)
This chart breaks down Par Drugs And Chemicals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Par Drugs And Chemicals Limited balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Par Drugs And Chemicals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Par Drugs And Chemicals Limited (2016–2026)
The table below shows the annual total liabilities of Par Drugs And Chemicals Limited from 2016 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs172.28 Million ≈ $1.86 Million |
-15.61% |
| 2025-03-31 | Rs204.15 Million ≈ $2.21 Million |
+27.76% |
| 2024-03-31 | Rs159.79 Million ≈ $1.73 Million |
-9.36% |
| 2023-03-31 | Rs176.30 Million ≈ $1.91 Million |
-6.29% |
| 2022-03-31 | Rs188.13 Million ≈ $2.03 Million |
-22.16% |
| 2021-03-31 | Rs241.70 Million ≈ $2.61 Million |
+23.94% |
| 2020-03-31 | Rs195.01 Million ≈ $2.11 Million |
-12.31% |
| 2019-03-31 | Rs222.38 Million ≈ $2.40 Million |
-33.10% |
| 2018-03-31 | Rs332.40 Million ≈ $3.59 Million |
-9.77% |
| 2017-03-31 | Rs368.38 Million ≈ $3.98 Million |
-9.43% |
| 2016-03-31 | Rs406.75 Million ≈ $4.40 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more